Clinical Trial Update: Effect of PTH(1-34) Treatment on Fracture Healing in Vivo [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating PTH(1-34) for fracture healing was withdrawn, with no reported results for shoulder or trochanteric fractures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Shoulder Fracture
• Trochanteric Fracture

Drugs mentioned

• PTH(1-34) (teriparatide)

Snippet

Sponsor: Glostrup University Hospital, Copenhagen | Conditions: Shoulder Fractures, Trochanteric Fractures | Phase 2 | Status: WITHDRAWN